Home
QGEN
QGEN News

Latest Qiagen N.V. (QGEN) News on October 21, 2025

Business Wire

8 days ago

QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast

Sizing Up Qiagen Shares in 2025 After Recent Earnings Momentum

Simply Wall St.

9 days ago

Sizing Up Qiagen Shares in 2025 After Recent Earnings Momentum

Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock?

Zacks

11 days ago

Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock?

QGEN vs. ACAD: Which Stock Is the Better Value Option?

Zacks

12 days ago

QGEN vs. ACAD: Which Stock Is the Better Value Option?

Why Analysts See Qiagen’s Outlook Shifting Amid New Guidance and Market Developments

Simply Wall St.

17 days ago

Why Analysts See Qiagen’s Outlook Shifting Amid New Guidance and Market Developments

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

Zacks

19 days ago

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing

Zacks

20 days ago

Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing

INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream

Zacks

a month ago

INCY Obtains FDA Approval for Label Expansion of Ruxolitinib Cream

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

GlobeNewswire

a month ago

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access

Insider Monkey

a month ago

Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access

QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio

Zacks

a month ago

QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx Portfolio

Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing

Insider Monkey

a month ago

Qiagen N.V. (QGEN) Launches QIAseq xHYB Panels for Long-Read Sequencing

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

Zacks

2 months ago

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

Business Wire

4 months ago

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

4 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Zacks

4 months ago

QGEN vs. EXAS: Which Stock Is the Better Value Option?

Here's Why Qiagen (QGEN) is a Strong Value Stock

Zacks

4 months ago

Here's Why Qiagen (QGEN) is a Strong Value Stock

Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy?

Zacks

4 months ago

Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy?

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

Insider Monkey

4 months ago

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

Here's Why Qiagen (QGEN) is a Strong Growth Stock

Zacks

4 months ago

Here's Why Qiagen (QGEN) is a Strong Growth Stock

QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock

Zacks

4 months ago

QIAGEN's New QIAcuity dPCR IVD Pact With GENCURIX May Boost Its Stock

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

Business Wire

4 months ago

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

Zacks

4 months ago

Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

MT Newswires

4 months ago

Sector Update: Health Care Stocks Flat to Higher Premarket Monday

QGEN Stock Rises in After Market Following Partnership With Incyte

Zacks

4 months ago

QGEN Stock Rises in After Market Following Partnership With Incyte

Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms

Medical Device Network

4 months ago

Qiagen and Incyte to develop diagnostic panel for myeloproliferative neoplasms

MT Newswires

4 months ago

QIAGEN, Incyte Partner to Develop NGS-Based Diagnostic Panel for Rare Blood Cancers

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

Business Wire

4 months ago

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

Should You Add QIAGEN Stock to Your Portfolio for Now?

Zacks

4 months ago

Should You Add QIAGEN Stock to Your Portfolio for Now?

Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?

Zacks

4 months ago

Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

Zacks

4 months ago

Here's Why Qiagen (QGEN) is a Strong Momentum Stock

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

Zacks

4 months ago

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term

Zacks

5 months ago

Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term

Here's Why Qiagen (QGEN) is a Strong Value Stock

Zacks

5 months ago

Here's Why Qiagen (QGEN) is a Strong Value Stock

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

Zacks

5 months ago

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

MT Newswires

5 months ago

Qiagen Enters Partnerships, Expands Portfolio for Minimal Residual Disease Testing in Oncology

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

Business Wire

5 months ago

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma

PR Newswire

5 months ago

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

Insider Monkey

5 months ago

Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research

QGEN Stock Might Gain Following New Partnership With ID Solutions

Zacks

5 months ago

QGEN Stock Might Gain Following New Partnership With ID Solutions

Medical Device Network

5 months ago

Qiagen and ID Solutions collaborate on dPCR assays for oncology research

MT Newswires

5 months ago

Qiagen Expands Oncology Research Portfolio in Partnership with ID Solutions

Business Wire

5 months ago

QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Zacks

5 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Here's Why Qiagen (QGEN) is a Strong Value Stock

Zacks

5 months ago

Here's Why Qiagen (QGEN) is a Strong Value Stock

Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings

Simply Wall St.

5 months ago

Some Investors May Be Willing To Look Past Qiagen's (NYSE:QGEN) Soft Earnings

Qiagen First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

5 months ago

Qiagen First Quarter 2025 Earnings: Beats Expectations

QIAGEN Stock Gains Following the Acquisition of Genoox

Zacks

5 months ago

QIAGEN Stock Gains Following the Acquisition of Genoox

MT Newswires

5 months ago

Qiagen Acquires Genoox for $70 Million

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

Business Wire

5 months ago

QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Simply Wall St.

5 months ago

The Qiagen N.V. (NYSE:QGEN) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Morningstar Research

5 months ago

Analyst Report: Qiagen N.V.

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

Zacks

5 months ago

QGEN Q1 Earnings and Revenues Top, Operating Margin Expands, Stock Up

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

Zacks

5 months ago

Here's What Key Metrics Tell Us About Qiagen (QGEN) Q1 Earnings

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

Zacks

5 months ago

Qiagen (QGEN) Q1 Earnings and Revenues Surpass Estimates

MT Newswires

5 months ago

Qiagen Q1 Adjusted Earnings, Revenue Rise; New $500 Million Stock Buyback Planned

Associated Press Finance

5 months ago

Qiagen: Q1 Earnings Snapshot

QIAGEN announces plans for transition in leadership of Supervisory Board

Business Wire

5 months ago

QIAGEN announces plans for transition in leadership of Supervisory Board

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

Business Wire

5 months ago

QIAGEN delivers solid Q1 2025 results exceeding outlook; will seek shareholder approval to initiate a dividend and new $500 mn repurchase

MT Newswires

5 months ago

Qiagen Plans to Initiate Dividend Payments

Qiagen NV (QGEN) Q1 2025 Earnings Report Preview: What To Expect

GuruFocus.com

5 months ago

Qiagen NV (QGEN) Q1 2025 Earnings Report Preview: What To Expect

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

Business Wire

5 months ago

QIAGEN to Propose Initiation of Annual Cash Dividend for Shareholder Approval at Annual General Meeting

Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics

Zacks

6 months ago

Stay Ahead of the Game With Qiagen (QGEN) Q1 Earnings: Wall Street's Insights on Key Metrics

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Zacks

6 months ago

QGEN or RGEN: Which Is the Better Value Stock Right Now?

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Zacks

6 months ago

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Zacks

6 months ago

Sangamo Therapeutics (SGMO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks

6 months ago

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

Business Wire

6 months ago

QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

Zacks

6 months ago

Why Qiagen (QGEN) is a Top Value Stock for the Long-Term

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Business Wire

6 months ago

QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Simply Wall St.

6 months ago

Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation?

Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

Zacks

6 months ago

Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

MT Newswires

6 months ago

Qiagen Plans 3 New Sample Preparation Instrument Launches Through 2026

MT Newswires

6 months ago

Market Chatter: Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

Business Wire

6 months ago

QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation

MT Newswires

6 months ago

BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating

Morningstar Research

6 months ago

Analyst Report: Qiagen N.V.

Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?

Zacks

6 months ago

Biogen (BIIB) Soars 5.7%: Is Further Upside Left in the Stock?

Business Wire

6 months ago

QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast

MT Newswires

6 months ago

Update: Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted -- Shares Rise

Morningstar Research

6 months ago

Analyst Report: Qiagen N.V.

MT Newswires

6 months ago

Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

Business Wire

6 months ago

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

Qiagen Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

7 months ago

Qiagen Full Year 2024 Earnings: EPS Misses Expectations

QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts

Business Wire

7 months ago

QIAGEN Launches QIAprep&amp Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts

Bio-Techne Opens New Customer Experience Centre in Germany

Zacks

7 months ago

Bio-Techne Opens New Customer Experience Centre in Germany

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

Business Wire

7 months ago

QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Simply Wall St.

7 months ago

Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?

Zacks

7 months ago

Is it Worth Retaining QIAGEN Stock in Your Portfolio Now?

The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses

Simply Wall St.

7 months ago

The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

Zacks

8 months ago

Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound?

FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B

Medical Device Network

8 months ago

FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B

QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel

Zacks

8 months ago

QGEN Stock Up on FDA Nod for Second QIAstat-Dx Gastrointestinal Panel

MT Newswires

8 months ago

Sector Update: Health Care Stocks Flat to Lower Premarket Thursday

MT Newswires

8 months ago

QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

Business Wire

8 months ago

QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now

Insider Monkey

8 months ago

Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now

MT Newswires

8 months ago

Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

Business Wire

8 months ago

QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing

2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%

Motley Fool

8 months ago

2 Recent Stock Splits You've Never Heard of That Certain Wall Street Analysts Think Could Soar 39% and 62%

Share on Social Networks: